Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:30 PM UTC
| NCT Number | NCT05431088 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE2 |
| Target Enrollment | 389 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT05431088 is currently recruiting participants. This phase2 study for sickle cell disease is actively seeking new participants at 46 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05431088 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05431088 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.